Biochemical and Biophysical Research Communications
Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production
Research highlights
► Resveratrol inhibits RANKL-induced osteoclastogenesis. ► Resveratrol induces apoptosis of differentiated osteoclasts. ► Sirt1 and ER(s) pathways are not involved in the inhibition of osteoclastogenesis by resveratrol. ► The inhibition of osteoclastogenesis is correlated with the inhibitory effects of resveratrol on ROS production.
Introduction
Resveratrol (RSV) is a polyphenol produced by certain plant species, including nuts, berries, and grapes. It is known to exert a variety of health benefits in mammals, among which the cancer chemopreventive and cardio- and neuro-protective properties have attracted most attention [1]. Its protective effects in bone have also been demonstrated. In ovariectomized rats, RSV feeding significantly inhibited the bone loss induced by estrogen deficiency [2], [3]; In rats under tail suspension, prior RSV treatment preserved trabecular bone in the hind-limb from disuse osteopenia [4]; In aged-mice, the onset of senile osteoporosis was markedly delayed after long-term feeding with RSV-containing foods [5]. These findings indicate that this natural substance might be useful in the treatment or prevention of osteoporosis but the underlying mechanism remains to be clarified.
Bone remodeling is dependent on a delicate balance between the activities of osteoblasts and osteoclasts. It has been shown that, through activation of estrogen receptors (ERs), RSV increased osteoblast proliferation, enhanced alkaline phosphatase (ALP) activity [6], and stimulated BMP-2 production [7]. In addition, through activation of Sirt1, a NAD-dependent protein deacetylase, RSV promoted mesenchymal stem cell differentiation toward osteoblastic lineage [8]. The direct effects of RSV on osteoclasts are relatively unclear. Studies of Naruse et al. [9] and Voronov et al. [10] showed that RSV did not affect osteoclastogenesis but could reverse the inhibition of osteoclastic resorption mediated by arylhydrocarbon receptor (AhR) agonists. In contrast, Boissy et al. [11] and Gabbay et al. [12] showed that RSV directly inhibited RANKL-induced osteoclastogenesis and attenuated the bone loss in castrated male mice. However, neither of these studies has investigated the intracellular mechanism(s) by which RSV exerts the effects.
Osteoclasts are formed by fusion of monocyte/macrophage precursors [13]. The receptor activator of NF-κB (nuclear factor-κB) ligand (RANKL) produced by osteoblasts plays a key role in osteoclast differentiation and activation [14]. In physiological milieu, the binding of RANKL to its receptor RANK on the surface of osteoclast precursors leads to the activation of TNF receptor-associated factor 6 (TRAF6), which subsequently stimulates the transcription of osteoclast associated genes (such as cathepsin K) and leads to the formation of multinucleated tartrate-resistant acid phosphatase (TRACP) positive giant cells [13]. As a widely used pre-osteoclast model, the murine macrophage/osteoclast precursor cell line RAW 264.7 cells differentiate into osteoclasts when stimulated with RANKL [15]. In the present study, RAW 264.7 cells were used to evaluate the effects of RSV on RANKL-induced osteoclastogenesis. We found that RSV dose-dependently inhibited RANKL-induced osteoclast differentiation and increased apoptosis of differentiated cells. We also found that the inhibition of RSV on RANKL-induced osteoclast differentiation was independent on both the Sirt1 and ERs pathways but was correlated with the inhibition of intracellular reactive oxygen species (ROS) production.
Section snippets
Reagents
Modified Eagle’s medium alpha (α-MEM), fetal bovine serum (FBS), L-Glutamine and Gentamicin were purchased from Gibco (Invitrogen). Recombinant mouse RANKL (462-TEC) was purchased from R&D Systems; RSV was purchased from Sigma–Aldrich, and EX-527 and ICI-182780 were from Tocris.
Cell culture
The murine RAW264.7 macrophage cell line was obtained from the American Type Culture Collection (ATCC). Cells were cultured in α-MEM medium supplemented with 10% FBS, 2 mM L-Glutamine and 50 μg/ml Gentamicin at 37 °C in a
RSV inhibited RANKL-induced osteoclast formation of RAW 264.7 cells
Different concentrations of RSV (0, 0.3, 1, 3, and 10 μM) were added to RAW 264.7 cells after stimulation with RANKL. As shown in Fig. 1, the number of TRACP-positive multinucleated cells reduced with increasing RSV concentration. To substantiate this finding, we further measured the expression of the specific osteoclast marker, cathepsin K. We found that the expression of cathepsin K was downregulated at both mRNA (Fig. 3E) and protein level (Fig. 3F) with the treatment of RSV. Taken together,
Discussion
At present the anti-resorptives remain the mainstay of osteoporosis management, however, the simultaneous inhibitory effects on bone remodeling can be a problem [16]. Bone anabolic compounds that stimulate osteoblast activity would be preferred for the treatment of established osteoporosis, but the application of agents such as parathyroid hormone (PTH), is limited by cost and concerns regarding its long-term safety [21]. From a botanical point of view, RSV belongs to a class of defence
Acknowledgments
This work is supported by the Ulla and Gustaf af Ugglas Foundation and Loo and Hans Ostermans Foundation for geriatric research.
References (36)
- et al.
Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span
Cell Metab.
(2008) - et al.
Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells
Biochem. Biophys. Res. Commun.
(1998) - et al.
Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol
J. Biol. Chem.
(2007) - et al.
Inhibition of osteoclast formation by 3-methylcholanthrene, a ligand for arylhydrocarbon receptor: suppression of osteoclast differentiation factor in osteogenic cells
Biochem. Pharmacol.
(2004) - et al.
Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration
Biochem. Pharmacol.
(2005) - et al.
The ascorbate synthesis pathway: dual role of ascorbate in bone homeostasis
J. Biol. Chem.
(2010) Anti-resorptive therapies for osteoporosis
Semin. Cell Dev. Biol.
(2008)- et al.
Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells
Toxicology
(2006) - et al.
A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation
Blood
(2005) - et al.
Regulation of inflammation and redox signaling by dietary polyphenols
Biochem. Pharmacol.
(2006)
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Lancet
Safety studies conducted on high-purity trans-resveratrol in experimental animals
Food Chem. Toxicol.
Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells
Eur. J. Pharmacol.
RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis
J. Biol. Chem.
Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes
Eur. J. Pharmacol.
Resveratrol: one molecule, many targets
IUBMB Life
Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats
J. Nutr. Sci. Vitaminol. (Tokyo)
Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model
J. Med. Food
Cited by (136)
Redox signaling and antioxidant defense in osteoclasts
2024, Free Radical Biology and MedicineResveratrol-loaded co-axial electrospun poly(ε-caprolactone)/chitosan/polyvinyl alcohol membranes for promotion of cells osteogenesis and bone regeneration
2023, International Journal of Biological MacromoleculesAMPK negatively regulates RANKL-induced osteoclast differentiation by controlling oxidative stress
2023, Free Radical Biology and MedicineUnderstanding the mechanistic potential of plant based phytochemicals in management of postmenopausal osteoporosis
2023, Biomedicine and PharmacotherapyROS-responsive resveratrol-loaded cyclodextrin nanomicelles reduce inflammatory osteolysis
2022, Colloids and Surfaces B: BiointerfacesRe-appraising the role of flavonols, flavones and flavonones on osteoblasts and osteoclasts- A review on its molecular mode of action
2022, Chemico-Biological Interactions